School of Medicine
Showing 501-520 of 531 Results
-
Joseph C. Wu, MD, PhD
Director, Stanford Cardiovascular Institute, Simon H. Stertzer, MD, Professor and Professor of Radiology
Current Research and Scholarly InterestsDrug discovery, drug screening, and disease modeling using iPSC.
-
Joy Wu
Associate Professor of Medicine (Endocrinology)
Current Research and Scholarly InterestsMy laboratory focuses on the pathways that regulate the differentiation of mesenchymal stem cells into the osteoblast and adipocyte lineages. We are also studying the role of osteoblasts in the hematopoietic and cancer niches in the bone marrow microenvironment.
-
Sean M. Wu
Professor of Medicine (Cardiovascular Medicine) and, by courtesy, of Pediatrics
Current Research and Scholarly InterestsMy lab seeks to identify mechanisms regulating cardiac lineage commitment during embryonic development and the biology of cardiac progenitor cells in development and disease. We believe that by understanding the transcriptional and epigenetic basis of cardiomyocyte growth and differentiation, we can identify the most effective ways to repair diseased adult hearts. We employ mouse and human embryonic and induced pluripotent stem cells as well as rodents as our in vivo models for investigation.
-
Timothy Ting-Hsuan Wu
MD Student, expected graduation Spring 2024
Ph.D. Student in Biochemistry, admitted Summer 2021
MSTP Student
Temp Employee, Medicine - Med/Pulmonary, Allergy & Critical Care MedicineCurrent Research and Scholarly InterestsMolecular and cellular basis of lung development, renewal and disease;
Single cell analysis of SARS-CoV-2 lung infection;
Vascular inflammation and immune dysregulation in pulmonary hypertension. -
Xiaokang Wu
Postdoctoral Scholar, Cardiovascular Institute
BioDr. Wu completed her medical degree and a Ph.D. in clinical medicine from West China Medical College. Following this, she underwent postdoctoral training at the Smidt Heart Institute of Cedars-Sinai Medical Center, where her research centered on endovascular inflammation, calcium regulation in HFpEF (Heart Failure with Preserved Ejection Fraction), and the potential of Cardiosphere-derived cells (CDCs) and their exosomes (CDCexo) in heart failure treatment. Building on her proficiency in calcium handling and cardiosphere-derived cell-based therapies in rodent models, Dr. Wu became a part of the Stanford Cardiovascular Institute. Here, she delved deeper into regenerative medicine solutions for cardiovascular ailments. Currently, Dr. Wu spearheads research on transthyretin cardiac amyloidosis (ATTR), a rare and devastating protein misfolding disease. Utilizing iPSC, animal models, and human samples, her pioneering work promises significant insights into this life-threatening condition, aiming to enhance patient outcomes.
